Your browser doesn't support javascript.
loading
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study.
Olszewski, Adam J; Phillips, Tycel J; Hoffmann, Marc S; Armand, Philippe; Kim, Tae Min; Yoon, Dok Hyun; Mehta, Amitkumar; Greil, Richard; Westin, Jason; Lossos, Izidore S; Munoz, Javier L; Sit, Jason; Wei, Michael C; Yang, Annie; Chen, Vivian; Purev, Enkhtsetseg; Yee, Donald L; Jaeger, Ulrich.
Afiliação
  • Olszewski AJ; Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI.
  • Phillips TJ; Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI.
  • Hoffmann MS; Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS.
  • Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Yoon DH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Mehta A; Division of Hematology and Oncology, University of Alabama School of Medicine, Birmingham, AL.
  • Greil R; IIIrd Medical Department, Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT), Paracelsus Medical University, Salzburg, Austria.
  • Westin J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Lossos IS; Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.
  • Munoz JL; Banner MD Anderson Cancer Center, Gilbert, AZ.
  • Sit J; Genentech, Inc., South San Francisco, CA.
  • Wei MC; Genentech, Inc., South San Francisco, CA.
  • Yang A; Genentech, Inc., South San Francisco, CA.
  • Chen V; Genentech, Inc., South San Francisco, CA.
  • Purev E; Genentech, Inc., South San Francisco, CA.
  • Yee DL; Genentech, Inc., South San Francisco, CA.
  • Jaeger U; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
Blood Adv ; 7(20): 6055-6065, 2023 10 24.
Article em En | MEDLINE | ID: mdl-37581593
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Idioma: En Ano de publicação: 2023 Tipo de documento: Article